NCT04522063

Brief Summary

This research has the following specific objectives:

  1. 1.To elucidate how within-person variation in lifestyle factors affect fluctuations in blood glucose concentrations in individuals at high risk of diabetes.This study will elucidate how variation in food intakes, physical activity, and psychological stress affect variation in blood glucose concentrations throughout the day. These results can identify potential targets for interventions to reduce excessive fluctuations in blood glucose concentrations.
  2. 2.To describe to what extent the response of individuals to a standardized meal tolerance test can predict real-life variation in blood glucose concentrations. This study will evaluate how much variation in glucose concentrations under real-life conditions can be explained by an individual's response to a standardized mixed meal tolerance test. This will provide insight into the relative importance of variation in dietary and other lifestyle behaviours on an individual's predisposition to higher blood glucose responses.
  3. 3.To elucidate the role of oral processing behaviour and saliva properties on blood glucose concentrations. This study will elucidate whether variation in oral processing behaviours (e.g. number of chews taken, oro-sensory exposure time) and saliva properties (a-amylase activity, flow rate) predicts variation in blood glucose concentrations across individuals.
  4. 4.To assess whether research collecting multiple repeated measures of food intake, activity, and stress is feasible in large-scale epidemiological studies.This study will provide important insights into the feasibility over the long-run to collect multiple repeated data points on lifestyle behaviours through mobile phone applications and 24-hour glucose and physical activity monitoring in large scale studies in the Singapore population.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2019

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 29, 2019

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 10, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 10, 2020

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

July 29, 2020

Completed
23 days until next milestone

First Posted

Study publicly available on registry

August 21, 2020

Completed
Last Updated

August 21, 2020

Status Verified

August 1, 2020

Enrollment Period

7 months

First QC Date

July 29, 2020

Last Update Submit

August 18, 2020

Conditions

Keywords

Eating behaviourEating rateGlycaemic responseSatiety

Outcome Measures

Primary Outcomes (17)

  • Habitual dietary habit

    Habitual dietary habits are measured using Food Frequency Questionnaire (FFQ) rating from "never or rarely" to "6+ a day", where 'never to rarely' means nil or scarce intake of the food item. Data is collected as part of the procedure in test session 1 (total duration of 3 hours).

    Baseline measure

  • Habitual food intake behaviour

    Food intake behaviour is assessed using a Three-Factor Eating Questionnaire (TFEQ) using a 4-point scale from "definitely true" (4) to "definitely false" (1), where higher score means greater agreement to the statement asked. Data is collected as part of the procedure in test session 1 (total duration of 3 hours).

    Baseline measure

  • Habitual stress level

    Stress level is assessed using a Kessler Psychological Distress Scale (K10) on likert scale from "All of the time" to "None of the time", where higher score indicates greater stress. Data is collected as part of the procedure in test session 1 (total duration of 3 hours).

    Baseline measure

  • Habitual sleep quality

    Sleep Questionnaire (Pittsburgh sleep quality index), including the input of sleep time and duration and questions on 4-point scale from "Not during the past month" (1) to "Three or more times a week"(4), where higher score indicates poorer sleep quality. Data is collected as part of the procedure in test session 1 (total duration of 3 hours).

    Baseline measure

  • Habitual physical activity

    Global Physical Activity Questionnaire (GPAQ) to evaluate on duration spent on different types of physical activity. Responses will be tabulated into MET, where higher MET refers to greater intensity of physical activity. Data is collected as part of the procedure in test session 1 (total duration of 3 hours).

    Baseline measure

  • Physical activity

    Physical activity is measured using a wrist-worn accelerometer as part of lifestyle factors outcome. Data will be collected over a period of 10 days after their clinic visit (session 1).

    10 days

  • Glucose concentration

    Glucose concentrations is measured using a continuous glucose monitor sensor. Data will be collected over a period of 10 days after their clinic visit (session 1).

    10 days

  • Self-reported food intake

    Self-reported food intake measurement (food diary record) through entering of food items and amount consumed during meal via mobile phone application

    10 days

  • Self-reported physical activity

    Self-reported physical activity through entering of activity type and duration via mobile phone application

    10 days

  • Self-reported stress level

    Self-reported stress level will be assessed using questions on a 4-point likert scale reported at a 4-hour interval, from 'not at all' to 'very', where higher score means greater stress level.

    10 days

  • Blood glucose concentrations in response to standardized mixed meal tolerance test

    Blood glucose response will be measured through blood samples collected via an antecubital catheter before eating and at respective time points after completion of standardized meal. (I.e. at 5 min, 10 min, 15 min, 30 min, 45 min, 60 min, 90 min and 120 min (8ml each)). Data is collected as part of the procedure in test session 1 (total duration of 3 hours).

    During test session 1 (day 1), up to 2 hours

  • Reported satiety in response to standardized mixed meal tolerance test

    Meal satiety responses using a visual analogue scale (VAS) will be collected on a laptop every 15 minutes during test session 1. VAS is anchored at 'Not at all full' (0) to 'Extremely full' (100), where a higher score will indicate greater satiety.

    During test session 1 (day 1), up to 2 hours

  • Oral processing behaviours of test meal

    Participants will be video-recorded to measure oral processing behaviour of the test meal. Test meal bolus collection (test session 1): Bolus particle size (oral processing behaviour measure) will be assessed by having participants chew a fixed mouthful of the test meal until ready to swallow, then expectorating it in a cup. Data is collected as part of the procedure in test session 1 (total duration of 3 hours).

    During test session 1 (day 1), up to 15 minutes

  • Saliva properties of test meal

    Participants will be video-recorded to measure oral processing behaviour of the test meal. Test meal bolus collection (test session 1): Saliva uptake (saliva properties) will be assessed by having participants chew a fixed mouthful of the test meal until ready to swallow, then expectorating it in a cup. Data is collected as part of the procedure in test session 1 (total duration of 3 hours).

    During test session 1 (day 1), up to 15 minutes

  • Oral processing behaviours of 3 test foods

    Participants will be video-recorded to measure oral processing behaviour. Bolus collection of 3 food items (test session 2): Bolus particle size (oral processing behaviour measure) of 3 food items will be assessed by having participants chew on 3 different test foods using a fixed protocol then expectorating it in a cup.

    During test session 2 (day 11), up to 1 hour

  • Saliva properties of 3 test foods

    Participants will be video-recorded to measure oral processing behaviour. Bolus collection of 3 food items and saliva collection (test session 2): Saliva uptake (saliva properties) of 3 food items will be assessed by having participants chew on 3 different test foods using a fixed protocol then expectorating it in a cup. To measure saliva flow rate and amylase (saliva properties), resting saliva will be taken by asking the participant to expectorate into a tube (approximately 5ml) while stimulated whole saliva samples will be collected by chewing on a clean, non-toxic inert Parafilm square and expectorating over a period of 5 minutes.

    During test session 2 (day 11), up to 1 hour

  • Compliance (response frequency) to multiple repeated self-reported measures

    Response frequency (i.e. 5 out of 10 responses = 50%) of all self-administered measurements through a mobile phone application will be assessed. At least 70% of completed data from each participant will be used as a benchmark to assess response compliance.

    After study completion, up to 24 weeks

Eligibility Criteria

Age21 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Adults in Singapore with higher risk of type 2 diabetes

You may qualify if:

  • Aged 21-60 years.
  • One of the following : pre-diabetes (as determined by previous HbA1C test within the range 42-47mmol/mol), family history of diabetes (mother, father, brother, sister, son, or daughter), or BMI 25-30 kg/m2.
  • Ownership of a compatible smartphone.
  • Access to a data plan.
  • Able to provide informed consent.
  • Healthy dentition with ability to bite, chew and swallow normally

You may not qualify if:

  • Known sensitivity to medical-grade adhesives
  • Bleeding disorders
  • Allergies to any ingredients of the standardised meal or test foods
  • Pregnant or lactating women
  • Participants who did not agree to be contacted for future research
  • Participants with conditions: diabetes mellitus, hypertension or thyroid disease, myocardial infarction in the past year, cancer history, or psychosocial impairment.
  • Participants taking aspirin for long-term medical conditions will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

National University Hospital, Centre for Translational Medicine

Singapore, 117599, Singapore

Location

Singapore Institute of Food and Biotechnology Innovation (SIFBI)/Clinical Nutrition Research Centre

Singapore, 117599, Singapore

Location

Related Publications (1)

  • Goh AT, Choy JYM, Chua XH, Ponnalagu S, Khoo CM, Whitton C, van Dam RM, Forde CG. Increased oral processing and a slower eating rate increase glycaemic, insulin and satiety responses to a mixed meal tolerance test. Eur J Nutr. 2021 Aug;60(5):2719-2733. doi: 10.1007/s00394-020-02466-z. Epub 2021 Jan 2.

MeSH Terms

Conditions

Feeding Behavior

Condition Hierarchy (Ancestors)

Behavior, AnimalBehavior

Study Officials

  • Rob Martinus van Dam, PhD

    rob.van.dam@nus.edu.sg

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Principal Investigator

Study Record Dates

First Submitted

July 29, 2020

First Posted

August 21, 2020

Study Start

July 29, 2019

Primary Completion

February 10, 2020

Study Completion

February 10, 2020

Last Updated

August 21, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will not share

Locations